en
en

Category

2017
10
Nov

Oneness Biotech has licensed out OB318, a novel drug candidate for hepatocellular carcinoma to Microbio Shanghai for co-development and commercialization in mainland China, Hong Kong and Macao.

2017 年 11 月 10 日,
  Published Date:2017-11-10 Original Link:https://www.onenessbio.com/en/news_detail123_1.htm Contact Us繁簡EN
Read More
12
Jan

35th Annual J.P. Morgan Healthcare Conference

2017 年 1 月 12 日,
Date 2017-01-12 Location Westin St. Francis Hotel Presentation Download Download Chinese Version Download English Version Note N/A
Read More